Cefepime Hydrochloride Injection, Powder, For Solution
Product Images NDC 0143-9477

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefepime Hydrochloride (NDC 0143-9477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Cefepime For Injection Novaplus 1)

Structure (Cefepime For Injection Novaplus 1)
Chemical structure of Cefepime Hydrochloride showing its molecular framework, including ring structures, functional groups, and associated atoms such as chlorine and sulfur, along with a water molecule (H2O).*
FDA Label Image

Vial Label (Cefepime For Injection Novaplus 2)

Vial Label (Cefepime For Injection Novaplus 2)
Cefepime Hydrochloride 1 gram per vial injection powder for solution label. The label indicates it is a single-dose vial intended for intravenous infusion, to be reconstituted prior to use. It is manufactured by Hikma Pharmaceuticals USA Inc. and includes handling and storage instructions with a barcode on the right side.*
FDA Label Image

Carton Label (Cefepime For Injection Novaplus 3)

Carton Label (Cefepime For Injection Novaplus 3)
Cefepime for Injection, USP 1 gram per vial, powder for solution, labeled for intravenous use. The sterile product comes in a pack of ten 1 gram single-dose vials by Hikma Pharmaceuticals USA Inc. Label instructions include reconstitution before intramuscular use and dilution before intravenous infusion, with storage guidance at 20°C to 25°C and protection from light.*
FDA Label Image

Vial Label (Cefepime For Injection Novaplus 4)

Vial Label (Cefepime For Injection Novaplus 4)
Cefepime Hydrochloride for Injection, USP 2 grams per vial powder for solution, single-dose vial. Label indicates dilution before intravenous infusion, with instructions and storage information. The labeler is Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Carton Label (Cefepime For Injection Novaplus 5)

Carton Label (Cefepime For Injection Novaplus 5)
Label for Cefepime Hydrochloride Injection, USP, 2 grams per vial, powder for intravenous solution by Hikma Pharmaceuticals USA Inc. The label instructs dilution before intravenous infusion and states sterility. It specifies storage between 20°C to 25°C, protection from light, and retention in the carton until use. Package contains 10 single-dose vials of 2 grams each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.